These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 30506673)

  • 1. Genetic Variants Associated With Vincristine-Induced Peripheral Neuropathy in Two Populations of Children With Acute Lymphoblastic Leukemia.
    Li L; Sajdyk T; Smith EML; Chang CW; Li C; Ho RH; Hutchinson R; Wells E; Skiles JL; Winick N; Martin PL; Renbarger JL
    Clin Pharmacol Ther; 2019 Jun; 105(6):1421-1428. PubMed ID: 30506673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemia.
    Diouf B; Crews KR; Lew G; Pei D; Cheng C; Bao J; Zheng JJ; Yang W; Fan Y; Wheeler HE; Wing C; Delaney SM; Komatsu M; Paugh SW; McCorkle JR; Lu X; Winick NJ; Carroll WL; Loh ML; Hunger SP; Devidas M; Pui CH; Dolan ME; Relling MV; Evans WE
    JAMA; 2015 Feb; 313(8):815-23. PubMed ID: 25710658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns and severity of vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia.
    Lavoie Smith EM; Li L; Chiang C; Thomas K; Hutchinson RJ; Wells EM; Ho RH; Skiles J; Chakraborty A; Bridges CM; Renbarger J
    J Peripher Nerv Syst; 2015 Mar; 20(1):37-46. PubMed ID: 25977177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vincristine-induced peripheral neuropathy in survivors of childhood acute lymphoblastic leukaemia.
    Tay CG; Lee VWM; Ong LC; Goh KJ; Ariffin H; Fong CY
    Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28139029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic polymorphisms and vincristine-induced peripheral neuropathy in patients treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone therapy.
    Sawaki A; Miyazaki K; Yamaguchi M; Takeuchi T; Kobayashi K; Imai H; Tawara I; Ono R; Nosaka T; Katayama N
    Int J Hematol; 2020 May; 111(5):686-691. PubMed ID: 31993939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective assessment of vincristine-induced peripheral neuropathy in paediatric acute lymphoblastic leukemia.
    Li T; Kandula T; Cohn RJ; Kiernan MC; Park SB; Farrar MA
    Clin Neurophysiol; 2023 Oct; 154():157-168. PubMed ID: 37633123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity as a Potential Risk Factor for Vincristine-induced Peripheral Neuropathy.
    Sajdyk TJ; Boyle FA; Foran KS; Tong Y; Pandya P; Smith EML; Ho RH; Wells E; Renbarger JL
    J Pediatr Hematol Oncol; 2020 Oct; 42(7):e637-e640. PubMed ID: 31634238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vincristine-induced neuropathy as the initial presentation of charcot-marie-tooth disease in acute lymphoblastic leukemia: a Pediatric Oncology Group study.
    Chauvenet AR; Shashi V; Selsky C; Morgan E; Kurtzberg J; Bell B;
    J Pediatr Hematol Oncol; 2003 Apr; 25(4):316-20. PubMed ID: 12679647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measuring vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia.
    Lavoie Smith EM; Li L; Hutchinson RJ; Ho R; Burnette WB; Wells E; Bridges C; Renbarger J
    Cancer Nurs; 2013; 36(5):E49-60. PubMed ID: 23842524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A cohort study of vincristine-induced peripheral neuropathy in children].
    Li C; Jin J; Huang J; Yang XY; Li Y; Yan YY; Yang C
    Zhongguo Dang Dai Er Ke Za Zhi; 2023 May; 25(5):470-475. PubMed ID: 37272172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic risk factors for VIPN in childhood acute lymphoblastic leukemia patients identified using whole-exome sequencing.
    Abaji R; Ceppi F; Patel S; Gagné V; Xu CJ; Spinella JF; Colombini A; Parasole R; Buldini B; Basso G; Conter V; Cazzaniga G; Leclerc JM; Laverdière C; Sinnett D; Krajinovic M
    Pharmacogenomics; 2018 Oct; 19(15):1181-1193. PubMed ID: 30191766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of pyridoxine plus pyridostigmine treatment on vincristine-induced peripheral neuropathy in pediatric patients with acute lymphoblastic leukemia: a single-center experience.
    Aydin Köker S; Gözmen S; Demirağ B; Ünalp A; Karapinar TH; Oymak Y; Gürbüz G; Öner Eİ; Vergin RC
    Neurol Sci; 2021 Sep; 42(9):3681-3686. PubMed ID: 33439396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RISK FACTORS OF VINCRISTINE-INDUCED PERIPHERAL NEUROPATHY IN ACUTE LYMPHOBLASTIC LEUKAEMIA CHILDREN.
    Tunjungsari DA; Gunawan PI; Ugrasena IDG
    J Med Invest; 2021; 68(3.4):232-237. PubMed ID: 34759136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Pharmacogenomics of Vincristine-Induced Neuropathy: On Pins and Needles.
    Berg SL; Parsons DW
    JAMA Oncol; 2015 Oct; 1(7):975-6. PubMed ID: 26181361
    [No Abstract]   [Full Text] [Related]  

  • 15. Precision medicine to improve the risk and benefit of cancer care: genetic factors in vincristine-related neuropathy.
    McLeod HL
    JAMA; 2015 Feb; 313(8):803-4. PubMed ID: 25710656
    [No Abstract]   [Full Text] [Related]  

  • 16. Vincristine-induced neuropathy in childhood ALL (acute lymphoblastic leukemia) survivors: prevalence and electrophysiological characteristics.
    Jain P; Gulati S; Seth R; Bakhshi S; Toteja GS; Pandey RM
    J Child Neurol; 2014 Jul; 29(7):932-7. PubMed ID: 23781018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vincristine-induced peripheral neuropathy in children with cancer: A systematic review.
    van de Velde ME; Kaspers GL; Abbink FCH; Wilhelm AJ; Ket JCF; van den Berg MH
    Crit Rev Oncol Hematol; 2017 Jun; 114():114-130. PubMed ID: 28477739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small-fiber neuropathy and pain sensitization in survivors of pediatric acute lymphoblastic leukemia.
    Lieber S; Blankenburg M; Apel K; Hirschfeld G; Hernáiz Driever P; Reindl T
    Eur J Paediatr Neurol; 2018 May; 22(3):457-469. PubMed ID: 29396168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Precision Medicine in Childhood Cancer: The Influence of Genetic Polymorphisms on Vincristine-Induced Peripheral Neuropathy.
    Marangoni-Iglecias L; Rojo-Tolosa S; Márquez-Pete N; Cura Y; Moreno-Toro N; Membrive-Jiménez C; Sánchez-Martin A; Pérez-Ramírez C; Jiménez-Morales A
    Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Metabolomics Approach for Early Prediction of Vincristine-Induced Peripheral Neuropathy.
    Verma P; Devaraj J; Skiles JL; Sajdyk T; Ho RH; Hutchinson R; Wells E; Li L; Renbarger J; Cooper B; Ramkrishna D
    Sci Rep; 2020 Jun; 10(1):9659. PubMed ID: 32541868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.